Predict your next investment

Corporation
HEALTHCARE | Biotechnology
perkinelmer.com

See what CB Insights has to offer

Investments

6

Portfolio Exits

6

Partners & Customers

10

Service Providers

3

About PerkinElmer

PerkinElmer is a biotechnology company that offers a diagnostics portfolio focused on reproductive health, infectious disease screening, and genomics offerings for oncology and other molecular tests through its wide range of instruments, reagents, assay platforms, and software offerings.

PerkinElmer Headquarter Location

940 Winter St.

Waltham, Massachusetts, 2451,

United States

781-663-6900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PerkinElmer

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find PerkinElmer in 3 Expert Collections, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

M

Medical Devices

3,607 items

Companies that received FDA De Novo clearances since 2010. Companies tagged as #FDADeNovos

H

Health Monitoring & Diagnostics

701 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

PerkinElmer Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

PerkinElmer Rank

Latest PerkinElmer News

Genetic Disorders Market Size Share, Global Industry Brief Analysis by Trend, Growth, Competition, COVID-19 Impact Analysis | Abbott; Amgen Inc., ELITechGroup, GW Pharmaceuticals plc, Pfizer Inc, PerkinElmer

Jan 18, 2022

| Abbott; Amgen Inc., ELITechGroup, GW Pharmaceuticals plc, Pfizer Inc, PerkinElmer An international Genetic Disorders market research report provides an analytical measurement of the main challenges faced by the business currently and in the upcoming years. It not only assists with the informed decision making but also helps with smart working. For research methodology, primary interviews with key opinion leaders, DBMR market position grid, DBMR market challenge matrix, secondary sources, and assumptions are taken into account. In no doubt, businesses will increase sustainability and profitability with this market research report. The world class Genetic Disorders report is also a helpful source of assistance and direction for companies and individuals interested in the industry. Get Free Sample PDF Copy (Including FULL TOC, Graphs And Tables) Of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-genetic-disorders-market Market Analysis and Insights: Genetic Disorders Market Report encompasses an infinite knowledge and knowledge on what the market’s definition, classifications, applications, and engagements are and also explains the drivers and restraints of the market which is obtained from SWOT analysis. Genetic Disorders market report makes available remarkable data along with future forecast and thorough analysis of the market on international and regional level. The market report also provides with the list of leading competitors along with the strategic insights and analysis of the key factors influencing the Genetic Disorders industry. Genetic Disorders report provides important information such as market growth, including the drivers, restraints, lucrative opportunities, industry-specific challenges, and recent. The report also provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, a list of prominent players operating in the market, and other global Genetic Disorders market trends. An absolute overview of the Genetic Disorders industry has been presented via the persuasive Genetic Disorders report which considers various aspects of product definition, market segmentation, and the existing retailer landscape. While generating this finest market research report, DBMR team focuses on the several key aspects which are vital for the client to succeed in the market. The data and information included in this market report helps industry take sound decisions and plan about the advertising and sales promotion strategy more successfully. Companies Mentioned in Genetic Disorders Market: Amicus Therapeutics, Inc., Alexion Pharmaceuticals, Inc., Sanofi, Takeda Pharmaceutical Company Limited, Vertex Pharmaceuticals Incorporated; F. Hoffmann-La Roche Ltd; Abbott; Amgen Inc., ELITechGroup, GW Pharmaceuticals plc., Pfizer Inc, PerkinElmer Inc, AutoGenomics, Bio-Rad Laboratories, Inc.; BioMarin, Sarepta Therapeutics GlobalGenetic Disorders Market Scope and Market Size On the basis of indication, the market is segmented into CF, DMD, LSD and PNH. On the basis of disease type, the genetic disorders market is segregated intoAlzheimer’sdisease, cancer, cystic fibrosis, sickle cellanemia, DMD, thalassemia, huntington’s disease, rare diseases and others. This Global Genetic Disorders Market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research portable oxygen concentrators market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. To Receive Extensive List Of Important Regions, Ask For TOC Here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-genetic-disorders-market Table Of Content: Global Genetic Disorders Market Research Report The report is mainly segmented into several key regions, with sales, revenue, market share and growth rate of Genetic Disorders in these regions, covering: Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study. Executive Summary: It covers industry trends with high focus on market use cases and top market trends, Genetic Disorders market share by regions, and global market size. It also covers market share and growth rate by regions. Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players. Breakdown by Segmentation: This section provides details about Genetic Disorders market size by product and application. Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast. Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details. Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges, opportunities, and drivers analyzed in the report. Key Findings of the Research Study Appendix: It includes details about research and methodology approach, research methodology, data sources, authors of the study, and a disclaimer. The titled segments and sub-section of the market are illuminated below By Indication (CF, DMD, LSD, PNH) By Disease Type (Alzheimer’s Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, DMD, Thalassemia, Huntington’s Disease, Rare Diseases, Others) Competitive Landscape and Genetic Disorders Market Share Analysis The major players covered in the genetic disorders market report are Amicus Therapeutics, Inc., Alexion Pharmaceuticals, Inc., Sanofi, Takeda Pharmaceutical Company Limited, Vertex Pharmaceuticals Incorporated; F. Hoffmann-La Roche Ltd; Abbott; Amgen Inc., ELITechGroup, GW Pharmaceuticals plc., Pfizer Inc, PerkinElmer Inc, AutoGenomics, Bio-Rad Laboratories, Inc.; BioMarin, Sarepta Therapeutics among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. Regional Growth Analysis: Europe (Germany, UK, France, Italy, Russia and Turkey, etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam) South America (Brazil etc.) Feel Free To Ask Question Before Purchasing The Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-genetic-disorders-market The Market insights of Genetic Disorders will improve the revenue impact of businesses in various industries by: Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Genetic Disorders Market Guiding stakeholders to identify key problem and Industry dynamics areas pertaining to their consolidation strategies in the global Genetic Disorders market and offers solutions Assessing the impact of changing regulatory dynamics in the regions, Import and Export Probabilities, Developments at Sales Outcome And Revenue Generation Predictions in which companies are keen on expanding their footprints Provides understanding of disruptive technology, Potential and niche segments/regions exhibiting promising growth trends to help businesses make their transitions smoothly Helping leading companies make strategy recalibrations ahead of their competitors and peers Offers insights into promising synergies for top players aiming to retain their leadership position in the market and supply side analysis of Genetic Disorders Market. Genetic Disorders market research report puts forth thorough overview of the market where it identifies industry trends, determines brand awareness and influence, provides industry insights and offers competitive intelligence. Why buy this report? The report offers a comprehensive evaluation of the Global Genetic Disorders Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies. The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry. The report includes in-depth market analysis using Porter’s 5 force model. The impact of Covid-19 on the market is also featured in the report. The latest industry analysis And survey on Genetic Disorders provides sales outlook in 30+ countries, across key categories. Insights and outlook on Genetic Disorders market drivers, trends, competitive analysis and research methodology and influencing factors are also included in the study. About Data Bridge Market Research: An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate. Contact Us:-

PerkinElmer Investments

6 Investments

PerkinElmer has made 6 investments. Their latest investment was in Virtuedx as part of their Series B on January 1, 2022.

CBI Logo

PerkinElmer Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/6/2022

Series B

Virtuedx

$100M

No

10

7/5/2021

Series A - III

Subscribe to see more

Subscribe to see more

10

6/21/2021

Series A

Subscribe to see more

Subscribe to see more

10

12/16/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

4/1/2005

Seed

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/6/2022

7/5/2021

6/21/2021

12/16/2020

4/1/2005

Round

Series B

Series A - III

Series A

Series A

Seed

Company

Virtuedx

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$100M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

10

10

10

10

PerkinElmer Portfolio Exits

6 Portfolio Exits

PerkinElmer has 6 portfolio exits. Their latest portfolio exit was PerkinElmer - Phenoptics on October 31, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/31/2018

Divestiture

2

12/22/2016

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

5/11/2016

Divestiture

Subscribe to see more

Subscribe to see more

10

11/29/2010

Divestiture

Subscribe to see more

Subscribe to see more

10

11/21/2008

Merger

Subscribe to see more

Subscribe to see more

10

Date

10/31/2018

12/22/2016

5/11/2016

11/29/2010

11/21/2008

Exit

Divestiture

Divestiture

Divestiture

Divestiture

Merger

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

PerkinElmer Acquisitions

32 Acquisitions

PerkinElmer acquired 32 companies. Their latest acquisition was BioLegend on July 26, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/26/2021

$99M

Acquired

7

6/22/2021

Series D

$99M

Acquired

5

5/17/2021

$99M

Acq - Pending

12

5/12/2021

Private Equity

Subscribe to see more

$99M

Subscribe to see more

10

1/7/2021

Series E+

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

7/26/2021

6/22/2021

5/17/2021

5/12/2021

1/7/2021

Investment Stage

Series D

Private Equity

Series E+

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$99M

Note

Acquired

Acquired

Acq - Pending

Subscribe to see more

Subscribe to see more

Sources

7

5

12

10

10

PerkinElmer Partners & Customers

10 Partners and customers

PerkinElmer has 10 strategic partners and customers. PerkinElmer recently partnered with GENWORKS Health on October 10, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

10/26/2021

Distributor

GENWORKS Health

India

PerkinElmer India Signs Distribution Agreement with GenWorks Health

PerkinElmer Inc. , a global leader committed to innovating for a healthier world , is collaborating with GenWorks Health to be the exclusive distributor of solutions in the PerkinElmer Inc. newborn and prenatal screening portfolio .

2

10/14/2021

Partner

LabCentral

United States

PerkinElmer : Collaborates With Leading Life Science Incubators LabCentral and MBC BioLabs to Help Further Drug Discovery

WHAT : PerkinElmer , Inc. a global leader committed to innovating for a healthier world , today announced it is collaborating with leading life science incubators LabCentral in Boston , Massachusetts and MBC BioLabs in San Francisco , California to provide innovative , drug discovery technologies , expertise and training to help pharma and biotech start-ups more quickly and accurately identify and accelerate potential clinical trial candidates .

1

9/30/2021

Partner

UPM Biomedicals

Finland

UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

2

2/22/2021

Partner

California Department of Public Health

United States

Subscribe to see more

Subscribe to see more

10

10/30/2020

Partner

Color

United States

Subscribe to see more

Subscribe to see more

0

Date

10/26/2021

10/14/2021

9/30/2021

2/22/2021

10/30/2020

Type

Distributor

Partner

Partner

Partner

Partner

Business Partner

GENWORKS Health

LabCentral

UPM Biomedicals

California Department of Public Health

Color

Country

India

United States

Finland

United States

United States

News Snippet

PerkinElmer India Signs Distribution Agreement with GenWorks Health

PerkinElmer Inc. , a global leader committed to innovating for a healthier world , is collaborating with GenWorks Health to be the exclusive distributor of solutions in the PerkinElmer Inc. newborn and prenatal screening portfolio .

PerkinElmer : Collaborates With Leading Life Science Incubators LabCentral and MBC BioLabs to Help Further Drug Discovery

WHAT : PerkinElmer , Inc. a global leader committed to innovating for a healthier world , today announced it is collaborating with leading life science incubators LabCentral in Boston , Massachusetts and MBC BioLabs in San Francisco , California to provide innovative , drug discovery technologies , expertise and training to help pharma and biotech start-ups more quickly and accurately identify and accelerate potential clinical trial candidates .

UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

2

10

0

PerkinElmer Service Providers

4 Service Providers

PerkinElmer has 4 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Acq - P2P

Investment Bank

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Acq - P2P

Subscribe to see more

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

PerkinElmer Team

25 Team Members

PerkinElmer has 25 team members, including current President, E. Kevin Hrusovsky.

Name

Work History

Title

Status

E. Kevin Hrusovsky

President

Current

Daniel R Marshak

President

Current

Robert A Barrett

Senior Vice President

Current

Gregory L. Summe

Chief Executive Officer

Former

Daniel Chelsky

President

Former

Name

E. Kevin Hrusovsky

Daniel R Marshak

Robert A Barrett

Gregory L. Summe

Daniel Chelsky

Work History

Title

President

President

Senior Vice President

Chief Executive Officer

President

Status

Current

Current

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.